Line Beaudet: Nothing to disclose Poster Session I - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P038 - ESOC25-564 TREATMENT OF ACUTE ISCHEMIC STROKE DUE TO ISOLATED POSTERIOR CEREBRAL ARTERY OCCLUSION: RESULTS FROM A MULTICENTER STUDY Javier Botia Barbera 1 , Ana Iglesias Mohedano 1 , Andres Garcia Pastor 1 , Elena de Celis Ruiz 2 , Ricardo Jaime Rigual 2 , Juan Granja Lopez 2 , Patricia Calleja Castao 3 , Fernando Ostos Moliz 3 , Pablo Montabes Medina 3 , Antonio Cruz Culebras 4 , Rocio Vera 4 , Jaime Alonso 5 , Santiago Trillo Senin 5 , Eduardo Escolar Escamilla 6 , Antonio Gil Nuez 1 1 Gregorio Maran University General Hospital, Vascular Neurology Section and Stroke Center, Department of Neurology, Madrid, Spain, 2 La Paz University Hospital, Madrid, Spain, 3 12 de Octubre University Hospital, Madrid, Spain, 4 Ramon y Cajal University Hospital, Madrid, Spain, 5 La Princesa University Hospital, Madrid, Spain, 6 Getafe University Hospital, Madrid, Spain Background and Aims: To compare the efficacy and safety of mechanical thrombectomy (MT) versus best medical treatment (BMT) in patients with acute ischemic stroke due to isolated posterior cerebral artery (PCA) occlusion
Psychiatry 86 , 216221 (2015)
Researchers have detected DSIP-like material in the brain, peripheral organs, and blood plasma of humans
There are generally three approaches: Topical application creams and serums applying the peptide directly to skin Subcutaneous injection used in clinical settings under professional supervision Microneedling-assisted delivery combining the peptide with skin needling for deeper absorption What Does a GHK-Cu Peptide Injection Dosage Chart Usually Show
